GLP-1 drugs beat metformin for weight control in teens with type 2 diabetes +++++

https://www.news-medical.net/news/20251110/GLP-1-drugs-beat-metformin-for-weight-control-in-teens-with-type-2-diabetes.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=gastroenterology_newsletter_17_november_2025 A new real-world study reveals that advanced GLP-1 therapies, including semaglutide and tirzepatide, provide comparable glycemic control while offering superior weight benefits compared to metformin in adolescents newly diagnosed with type 2 diabetes. Scientists debunk gut microbiome-autism connection https://www.news-medical.net/news/20251113/Scientists-debunk-gut-microbiome-autism-connection.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=gastroenterology_newsletter_17_november_2025 New precision therapies reshape the future of pancreatitis treatmentNew precision therapies reshape the future of pancreatitis treatment https://www.news-medical.net/news/20251111/New-precision-therapies-reshape-the-future-of-pancreatitis-treatment.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=gastroenterology_newsletter_17_november_2025 Pancreatitis remains a major global health burden, encompassing acute pancreatitis (AP), chronic pancreatitis (CP), and autoimmune pancreatitis (AIP). Collaborative effort advances next-generation therapies for pancreatic and GI cancersCollaborative effort advances next-generation therapies for pancreatic and GI cancers https://www.news-medical.net/news/20251112/Collaborative-effort-advances-next-generation-therapies-for-pancreatic-and-GI-cancers.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=gastroenterology_newsletter_17_november_2025 Last year, researchers at the University of California, Riverside, developed a novel "molecular crowbar" strategy to degrade the oncogenic enzyme Pin1, a protein that is overexpressed in many tumors including pancreatic cancer. Johns Hopkins study links mild pancreatic duct dilatation to higher cancer riskJohns Hopkins study links mild pancreatic duct dilatation to higher cancer risk https://www.news-medical.net/news/20251114/Johns-Hopkins-study-links-mild-pancreatic-duct-dilatation-to-higher-cancer-risk.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=gastroenterology_newsletter_17_november_2025 Pancreatic ductal adenocarcinoma is projected to become the second-leading cause of cancer death in the United States by 2030, according to the National Institutes of Health (NIH)